Conference
Interim analysis of a phase II trial of 5-azacitidine (5AC) and entinostat (SNDX-275) in relapsed advanced lung cancer (NSCLC)
Abstract
8055
Authors
Juergens RA; Vendetti F; Coleman B; Sebree RS; Rudek MA; Belinsky S; Brock M; Herman J; Baylin S; Rudin CM
Volume
27
Pagination
pp. 8055-8055
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2009
DOI
10.1200/jco.2009.27.15_suppl.8055
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X